Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia
Dongqing Yan, Anca Franzini, Anthony D. Pomicter, et al.
Blood Cancer Discovery (2021) Vol. 2, Iss. 3, pp. 266-287
Open Access | Times Cited: 48

Showing 26-50 of 48 citing articles:

Non-oncogene dependencies: Novel opportunities for cancer therapy
Tiziana Di Marco, Mara Mazzoni, Angela Greco, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116254-116254
Closed Access | Times Cited: 3
Virtual Screening in the Identification of Sirtuins’ Activity Modulators
Elena Abbotto, Naomi Scarano, Francesco Piacente, et al.
Molecules (2022) Vol. 27, Iss. 17, pp. 5641-5641
Open Access | Times Cited: 15
Sirtuin 5-driven meiotic spindle assembly and actin-based migration in mouse oocyte meiosis
Cong Ma, Xueke Zhang, Yingying Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e32466-e32466
Open Access | Times Cited: 2
Plant-derived extracts and metabolic modulation in leukemia: a promising approach to overcome treatment resistance
Cindy Arévalo, Nataly Cruz-Rodríguez, Sandra Quijano, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 5
Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies
Zsuzsanna Gaál
Biomolecules (2022) Vol. 13, Iss. 1, pp. 61-61
Open Access | Times Cited: 8
A new view on functions of the lysine demalonylase activity of SIRT5
Jarmila Nahálková
Life Sciences (2023) Vol. 320, pp. 121572-121572
Open Access | Times Cited: 4
Histidine re-sensitizes pediatric acute lymphoblastic leukemia to 6-mercaptopurine through tetrahydrofolate consumption and SIRT5-mediated desuccinylation
Na Dong, Huixian Ma, Xueqin Liu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 1
Sirtuin 5 regulates acute myeloid leukemia cell viability and apoptosis by succinylation modification of glycine decarboxylase
Jun Zhang, Cheng Luo, Haiying Long
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Malignant growth of arsenic-transformed cells depends on activated Akt induced by reactive oxygen species
Qun Lou, Fuxun Chen, Bingyang Li, et al.
International Journal of Environmental Health Research (2022) Vol. 33, Iss. 3, pp. 284-298
Closed Access | Times Cited: 6
Genomic Abnormalities as Biomarkers and Therapeutic Targets in Acute Myeloid Leukemia
Sara Ribeiro, Anna M. Eiring, Jamshid S. Khorashad
Cancers (2021) Vol. 13, Iss. 20, pp. 5055-5055
Open Access | Times Cited: 8
Investigation of Carboxylic Acid Isosteres and Prodrugs for Inhibition of the Human SIRT5 Lysine Deacylase Enzyme**
Nima Rajabi, Tobias Hansen, Alexander L. Nielsen, et al.
Angewandte Chemie (2022) Vol. 134, Iss. 22
Open Access | Times Cited: 5
Deciphering Metabolic Adaptability of Leukemic Stem Cells
Sweta B. Patel, Travis Nemkov, Angelo D’Alessandro, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Non-oncogene Addiction to SIRT5 in Acute Myeloid Leukemia
Meng Li, Ari Melnick
Blood Cancer Discovery (2021) Vol. 2, Iss. 3, pp. 198-200
Open Access | Times Cited: 5
SIRT5’s GOT1 up on PDAC
Surinder Kumar, David B. Lombard
Gastroenterology (2021) Vol. 161, Iss. 5, pp. 1376-1378
Open Access | Times Cited: 4
Human SIRT5 variants with reduced stability and activity do not cause neuropathology in mice
Taolin Yuan, Surinder Kumar, Mary E. Skinner, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109991-109991
Open Access
Mechanism-based inactivators of sirtuin 5: A focused structure–activity relationship study
Tobias Hansen, Xinyi Yuan, Margarida Santana, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 115, pp. 130017-130017
Open Access
Bioluminescence assay of lysine deacylase sirtuin activity
Alexandria N. Van Scoyk, Orlando Antelope, Donald E. Ayer, et al.
Cell chemical biology (2024) Vol. 31, Iss. 11, pp. 2002-2014.e4
Open Access
Reframing thalassaemia syndrome as a benign haematopoietic stem cell disorder
Aurelio Maggio, Mariasanta Napolitano, Alì Taher, et al.
British Journal of Haematology (2024)
Closed Access
Circular RNAs and Untranslated Regions in Acute Myeloid Leukemia
Shih-Chia Yeh, Faith J. F. Cheong, Yvonne Tay
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3215-3215
Open Access | Times Cited: 1
Aryl Fluorosulfate Based Inhibitors That Covalently Target the SIRT5 Lysine Deacylase**
Julie E. Bolding, Pablo Martín‐Gago, Nima Rajabi, et al.
Angewandte Chemie (2022) Vol. 134, Iss. 47
Open Access | Times Cited: 2
SLC25A51 impacts drug sensitivity in AML cells by sustaining mitochondrial oxidative flux
Mu‐Jie Lu, Jonathan Busquets, Valeria Impedovo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
SIRT5variants from patients with mitochondrial disease are associated with reduced SIRT5 stability and activity, but not with neuropathology
Taolin Yuan, Surinder Kumar, Mary E. Skinner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
A new view on functions of the lysine demalonylase activity of SIRT5
Jarmila Nahálková
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Previous Page - Page 2

Scroll to top